March 30, 2025 - 15:10

In a significant shakeup within the nation’s health agency, the FDA's leading vaccine official, Dr. Peter Marks, has resigned amid rising tensions. Dr. Marks expressed concerns over Health Secretary Robert F. Kennedy Jr.'s alleged demand for "subservient confirmation" of what he described as misinformation and lies. This resignation comes on the heels of a startling announcement from the Department of Health and Human Services (HHS), which revealed plans to lay off approximately 10,000 workers.
The implications of these developments are profound, as they could hinder the agency's ability to respond effectively to public health challenges. Experts warn that such drastic cuts may lead to a decrease in oversight and support for vital health initiatives, potentially jeopardizing the safety and efficacy of vaccines and other critical health programs. Former HHS leaders have voiced their concerns about the long-term effects on public health infrastructure, emphasizing the need for a stable and informed leadership to navigate ongoing health crises.
August 6, 2026 - 20:21
Reimagining Rural Maternal and Child HealthMaternal and child health outcomes remain a serious national issue, even with ongoing programs, local efforts, and executive actions designed to improve population health and prevent deaths. While...
August 6, 2026 - 10:04
Stop asking if AI is good for medicineThe question of whether artificial intelligence is good for medicine has become a tired debate. It is the wrong question. AI is not a single thing. It is a collection of tools, each with different...
August 5, 2026 - 18:11
Erica Schwartz confirmed as CDC director, filling nearly year-long vacancyThe U.S. Senate has officially confirmed Erica Schwartz as the new director of the Centers for Disease Control and Prevention, ending a vacancy that stretched nearly a full year. Schwartz becomes...
August 5, 2026 - 06:45
Manipal Health Enterprises Stock Prices Surge 11% After $975 Million India IPOThe hospital operator Manipal Health Enterprises saw its stock price climb more than 11 percent in its market debut on Wednesday, capping off a successful initial public offering that raised close...